End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 22 | 3Sbio Inc. Announces Management Changes | CI |
Apr. 15 | 3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia | MT |
Sales 2023 | 7.82B 1.08B | Sales 2024 * | 8.65B 1.19B | Capitalization | 13.34B 1.84B |
---|---|---|---|---|---|
Net income 2023 | 1.55B 214M | Net income 2024 * | 1.93B 267M | EV / Sales 2023 | 2.37 x |
Net Debt 2023 | 2.15B 297M | Net Debt 2024 * | 866M 120M | EV / Sales 2024 * | 1.64 x |
P/E ratio 2023 |
11
x | P/E ratio 2024 * |
7.36
x | Employees | - |
Yield 2023 * |
2.87% | Yield 2024 * |
3.89% | Free-Float | 73.96% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Xiang He
DFI | Director of Finance/CFO | - | 23-07-02 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Huang
BRD | Director/Board Member | 63 | 92-12-31 |
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
1st Jan change | Capi. | |
---|---|---|
-2.86% | 87.31B | |
+2.63% | 40.86B | |
-21.76% | 29.36B | |
+58.56% | 24.49B | |
-14.78% | 17.31B | |
-18.49% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B |